Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Sunday, November 24, 2024.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2025 (2024-11-24): -92.25%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-60.32%
RETURN ON EQUITY (ROE) AVG 3Y
-116.17%
RETURN ON EQUITY (ROE) AVG 5Y
-44.88%
RETURN ON EQUITY (ROE) AVG 10Y
-4.78%
RETURN ON EQUITY (ROE) AVG 15Y
-0.09%
RETURN ON EQUITY (ROE) AVG 20Y
4.16%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Lifecore Biomedical, Inc.
Market Cap
$241.94M
Return on Equity (ROE)
N/A
TTM Avg
-60.32%
3Y Avg
-116.17%
5Y Avg
-44.88%
Market Cap
$241.39M
Return on Equity (ROE)
31.90%
TTM Avg
-385.06%
3Y Avg
-191.20%
5Y Avg
-142.10%
Market Cap
$241.34M
Return on Equity (ROE)
-54.67%
TTM Avg
-46.45%
3Y Avg
-41.29%
5Y Avg
-47.75%
Market Cap
$239.02M
Return on Equity (ROE)
-47.25%
TTM Avg
-42.23%
3Y Avg
-50.43%
5Y Avg
-29.25%
Market Cap
$239.01M
Return on Equity (ROE)
-31.55%
TTM Avg
-30.05%
3Y Avg
-33.97%
5Y Avg
-37.95%
Market Cap
$237.57M
Return on Equity (ROE)
-59.27%
TTM Avg
-136.66%
3Y Avg
-113.26%
5Y Avg
-53.68%
Market Cap
$236.82M
Return on Equity (ROE)
-25.20%
TTM Avg
-25.82%
3Y Avg
5.12%
5Y Avg
5.12%
Market Cap
$247.27M
Return on Equity (ROE)
-33.97%
TTM Avg
-31.77%
3Y Avg
-42.34%
5Y Avg
-36.86%
Market Cap
$247.62M
Return on Equity (ROE)
N/A
TTM Avg
35.05%
3Y Avg
64.68%
5Y Avg
-167.54%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lifecore Biomedical, Inc. (LFCR) | $241.94M | N/A | -60.32% | -116.17% | -44.88% |
| Q32 Bio Inc. (QTTB)vs › | $241.39M | 31.90% | -385.06% | -191.20% | -142.10% |
| Quantum-Si incorporated (QSI)vs › | $241.34M | -54.67% | -46.45% | -41.29% | -47.75% |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | -47.25% | -42.23% | -50.43% | -29.25% |
| High Tide Inc. (HITI)vs › | $239.01M | -31.55% | -30.05% | -33.97% | -37.95% |
| Invivyd, Inc. (IVVD)vs › | $237.57M | -59.27% | -136.66% | -113.26% | -53.68% |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | -25.20% | -25.82% | 5.12% | 5.12% |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $247.27M | -33.97% | -31.77% | -42.34% | -36.86% |
| Galectin Therapeutics Inc. (GALT)vs › | $247.62M | N/A | 35.05% | 64.68% | -167.54% |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | -1.67% | 19.58% | 23.42% | 29.49% |
ROE
N/A
ROA
N/A
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2024-11-24 | -92.25% |
| 2024-05-26 | 106.17% |
| 2024-02-25 | -93.15% |
| 2023-11-26 | -162.04% |
| 2023-08-27 | -360.16% |
| 2023-02-26 | -283.40% |
| 2022-11-27 | -99.13% |
| 2022-08-28 | -102.33% |
| 2022-05-29 | -111.21% |
| 2022-02-28 | -44.33% |
| 2021-11-30 | -36.03% |
| 2021-08-31 | -16.06% |
| 2021-05-31 | -16.11% |
| 2021-02-28 | -21.97% |
| 2020-11-30 | -24.39% |
| 2020-08-31 | -20.08% |
| 2020-05-31 | -16.53% |
| 2020-02-29 | -9.41% |
| 2019-11-30 | -4.14% |
| 2019-08-31 | -1.72% |
| 2019-05-31 | 0.15% |
| 2019-02-28 | 2.51% |
| 2018-11-30 | 8.60% |
| 2018-08-31 | 9.03% |
| 2018-05-31 | 9.83% |
| 2018-02-28 | 8.52% |
| 2017-11-30 | 3.71% |
| 2017-08-31 | 4.11% |
| 2017-05-31 | 4.67% |
| 2017-02-28 | 5.78% |
| 2016-11-30 | -5.42% |
| 2016-08-31 | -5.24% |
| 2016-05-31 | -5.52% |
| 2016-02-29 | -5.94% |
| 2015-11-30 | 5.68% |
| 2015-08-31 | 6.36% |
| 2015-05-31 | 6.20% |
| 2015-02-28 | 6.49% |
| 2014-11-30 | 7.88% |
| 2014-08-31 | 8.14% |
| 2014-05-31 | 9.43% |
| 2014-02-28 | 9.66% |
| 2013-11-30 | 9.28% |
| 2013-08-31 | 12.51% |
| 2013-05-31 | 11.62% |
| 2013-02-28 | 10.99% |
| 2012-11-30 | 11.44% |
| 2012-08-31 | 8.76% |
| 2012-05-31 | 8.48% |
| 2012-02-29 | 4.85% |
| 2011-11-30 | 3.35% |
| 2011-08-31 | 2.46% |
| 2011-05-31 | 2.88% |
| 2011-02-28 | 3.71% |
| 2010-11-30 | 3.39% |
| 2010-08-31 | 3.07% |
| 2010-05-31 | 3.05% |
| 2010-02-28 | 5.83% |
| 2009-11-30 | 5.74% |
| 2009-08-31 | 5.83% |
| 2009-05-31 | 6.49% |
| 2009-02-28 | 7.51% |
| 2008-11-30 | 9.56% |
| 2008-08-31 | 11.05% |
| 2008-05-31 | 11.72% |
| 2008-02-29 | 13.60% |
| 2007-11-30 | 35.10% |
| 2007-08-31 | 33.56% |
| 2007-05-31 | 26.48% |
| 2007-02-28 | 29.76% |
| 2006-11-30 | 11.93% |
| 2006-08-31 | 10.72% |
| 2006-05-31 | 10.17% |
| 2006-02-28 | 8.41% |
| 2005-11-30 | 7.43% |
| 2005-08-31 | 7.76% |
| 2005-05-31 | 7.50% |
| 2005-02-28 | 7.51% |
| 2004-11-30 | 5.23% |
| 2004-08-31 | 4.26% |
| 2004-05-31 | 4.33% |
| 2003-04-30 | -1.47% |
